UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net (loss) income including noncontrolling interests in subsidiaries	$ (34,698)	$ 68,930
Adjustments to reconcile net (loss) income including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:
Depreciation, depletion and amortization	33,574	14,728
Accretion of asset retirement obligation	986	0
Change in fair value of Series A redeemable convertible preferred stock embedded derivatives	0	(3,954)
Change in fair value of Series B warrants	0	(2,762)
Gain on exercise of Series B warrants	0	(1,525)
Compensation expense for share-based awards	4,795	3,297
Loss (gain) on foreign currency exchange	370	(53)
Change in fair value of equity securities	31,412	(31,423)
(Gain) loss on sale of equity securities	(28,861)	10,930
Earnings on equity investment in joint venture	0	(4,167)
Unrealized loss (gain) on derivatives	610	(781)
Deferred income taxes, net of acquired net deferred tax assets	(6,051)	(3,657)
Changes in assets and liabilities:
Accounts receivable	69,225	(70,313)
Inventories	1,054	3,301
Prepaid expenses and other assets	(9,329)	(820)
Accounts payable and accrued expenses	(8,124)	(4,651)
Royalties and contingent legal fees payable	(5,338)	751
Deferred revenue	497	(337)
Net cash provided by (used in) operating activities	50,122	(22,506)
Cash flows from investing activities:
Acquisition, net of cash acquired (Note 3)	(87,678)	(9,409)
Cash reinvested	0	9,965
Patent acquisition	(14,000)	(6,000)
Purchases of equity securities	(20,472)	(13,072)
Sales of equity securities	57,854	32,106
Distributions received from equity investment in joint venture	0	2,777
Net purchases of property and equipment and additions to oil and gas properties	(148,667)	(189)
Net cash (used in) provided by investing activities	(212,963)	16,178
Cash flows from financing activities:
Repurchase of common stock	(20,288)	0
Paydown of Senior Secured Notes	0	(60,000)
Contributions from noncontrolling interest	15,250	0
Borrowings on the Revolving credit facility	86,010	0
Paydown of Revolving Credit Facility	(30,035)	(7,700)
Borrowings on the Term Loan	47,488	0
Dividend on Series A Redeemable Convertible Preferred Stock	0	(1,400)
Taxes paid related to net share settlement of share-based awards	(1,092)	(614)
Proceeds from exercise of stock options	223	235
Net cash provided by financing activities	97,556	58,632
Effect of exchange rates on cash and cash equivalents	(926)	1
(Decrease) increase in cash and cash equivalents	(66,211)	52,305
Cash and cash equivalents, beginning	340,091	287,786
Cash and cash equivalents, ending	273,880	340,091
Supplemental schedule of cash flow information:
Interest paid	5,058	2,513
Income taxes paid	1,048	831
Noncash investing and financing activities:
Accrued patent costs	0	4,000
Distribution to noncontrolling interests in subsidiaries	0	1,390
Rights Offering
Cash flows from financing activities:
Proceeds from Warrant Exercises	0	79,111
Series B
Cash flows from financing activities:
Proceeds from Warrant Exercises	$ 0	$ 49,000